美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
APRESOLINE-ESIDRIX	012026	002	NDA	HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;15MG	No	No	--	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
ESIDRIX	011793	005	NDA	HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG	No	No	1959/02/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
ESIDRIX	011793	008	NDA	HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG	No	No	1959/02/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
ESIDRIX	011793	009	NDA	HYDROCHLOROTHIAZIDE	TABLET;ORAL	100MG	No	No	1959/02/12	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL-ESIDRIX #1	011878	003	NDA	HYDROCHLOROTHIAZIDE; RESERPINE	TABLET;ORAL	25MG;0.1MG	No	No	1959/05/05	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
SERPASIL-ESIDRIX #2	011878	005	NDA	HYDROCHLOROTHIAZIDE; RESERPINE	TABLET;ORAL	50MG;0.1MG	No	No	1959/05/05	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued